Claritev (CTEV) AI Stock Analysis

• Market Cap: $910.40M
• Dividend Yield: N/A
• Average Volume (3M): 131.70K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.72
• Revenue Growth: -2.03%
• EPS Growth: 43.59%
• Country: US
• Employees: 2,700
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -3.81
• Shares Outstanding: 16,474,834
• 10 Day Avg. Volume: 120,165
• 30 Day Avg. Volume: 131,699
• PEG Ratio: >-0.01
• Price to Book (P/B): 5.61
• Price to Sales (P/S): 0.51
• P/FCF Ratio: -44.88
• Enterprise Value/Market Cap: 5.85
• Enterprise Value/Revenue: 5.69
• Enterprise Value/Gross Profit: 9.10
• Enterprise Value/Ebitda: 280.82
• 1Y Price Target: $80.00
• Price Target Upside: 16.62% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 48 Neutral
• Price Target: $65.00 ▼(-5.25% Downside)

Claritev's overall stock score is primarily impacted by its weak financial performance, characterized by high leverage and negative profitability. While technical analysis shows some bullish momentum, valuation challenges due to ongoing losses further weigh down the score.

Claritev Business Overview & Revenue Model

Company Description

Claritev (CTEV) is a technology-driven company specializing in innovative solutions for the telecommunications and data management sectors. The company focuses on providing cutting-edge software applications and platforms that enhance communication efficiency, streamline data processing, and improve overall operational productivity for businesses. With a commitment to leveraging advanced technologies such as artificial intelligence and cloud computing, Claritev aims to empower organizations to optimize their workflows and enhance customer engagement through its robust suite of products and services.

How the Company Makes Money

Claritev generates revenue primarily through a subscription-based model for its software applications, offering tiered pricing plans based on the features and services utilized by its clients. Additionally, the company earns income through implementation services, where it assists businesses in integrating its solutions into their existing systems. Claritev also engages in strategic partnerships with telecommunications providers and technology firms to expand its market reach, which contributes to its revenue through joint ventures and co-branded product offerings. Furthermore, the company may earn revenue from consultancy services, providing expert advice and tailored solutions to enhance operational efficiency for its clients.

Claritev Financial Statement Overview

Summary

Claritev faces significant financial challenges, with a negative net profit margin and high leverage. The negative equity and cash flow issues further exacerbate financial instability, posing risks to long-term sustainability.

Income Statement

Claritev's income statement reveals significant challenges. The TTM data shows a negative net profit margin of -126.96%, indicating substantial losses. Revenue growth is positive at 87.3% TTM, but this is overshadowed by negative EBIT and EBITDA margins, suggesting operational inefficiencies. Historical data shows a declining trend in profitability, with consistent negative net income over the years.

Balance Sheet

The balance sheet highlights financial instability, with a concerning debt-to-equity ratio of 312.43 in the TTM period, reflecting high leverage. Stockholders' equity is negative, indicating potential solvency issues. The return on equity is also negative, suggesting poor returns for shareholders. These factors point to significant financial risk.

Cash Flow

Cash flow analysis shows mixed results. The operating cash flow to net income ratio is positive at 0.15 TTM, indicating some cash generation capability. However, free cash flow is negative, and its growth rate is declining, which could impact future liquidity. The free cash flow to net income ratio is also negative, reflecting cash flow challenges.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	935.54M	930.62M	961.52M	1.08B	1.12B	937.76M
Gross Profit	585.09M	691.22M	726.06M	875.62M	942.31M	619.09M
EBITDA	18.96M	-1.01B	651.93M	158.32M	814.99M	192.41M
Net Income	-663.37M	-1.65B	-91.70M	-572.91M	102.08M	-520.56M
Balance Sheet
Total Assets	5.07B	5.15B	6.96B	7.37B	8.22B	8.28B
Cash, Cash Equivalents and Short-Term Investments	56.39M	16.85M	71.55M	334.05M	185.33M	126.75M
Total Debt	4.57B	4.54B	4.57B	4.78B	4.93B	4.61B
Total Liabilities	5.11B	5.07B	5.26B	5.58B	5.88B	5.73B
Stockholders Equity	-39.91M	84.02M	1.71B	1.79B	2.34B	2.56B
Cash Flow
Free Cash Flow	-55.01M	-10.51M	62.87M	282.63M	320.10M	306.56M
Operating Cash Flow	70.61M	107.62M	171.72M	372.36M	404.69M	377.37M
Investing Cash Flow	-125.62M	-118.12M	-249.79M	-104.45M	-228.38M	-210.84M
Financing Cash Flow	63.13M	-41.31M	-180.99M	-115.74M	-114.68M	-61.60M

Claritev Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 68.60
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTEV, the sentiment is Positive. The current price of 68.6 is above the 20-day moving average (MA) of 59.35, above the 50-day MA of 60.94, and above the 200-day MA of 38.26, indicating a bullish trend. The MACD of 3.63 indicates Negative momentum. The RSI at 64.24 is Neutral, neither overbought nor oversold. The STOCH value of 91.48 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CTEV.

Claritev Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NUTX	―	$710.11M	10.74	―	―	141.25%	―
HSTM	―	$729.17M	38.82	5.81%	0.49%	3.50%	13.99%
HCAT	―	$235.05M	―	-28.42%	―	5.55%	-0.99%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
CTEV	―	$910.40M	―	-235.47%	―	-2.03%	43.59%
EVH	―	$831.96M	―	-13.38%	―	-6.71%	-71.40%
DH	―	$408.92M	―	-64.27%	―	-5.24%	23.59%

Claritev Corporate Events

Claritev Secures Renewals with Major Clients

On October 15, 2025, Claritev Corporation successfully renewed contracts with its ten largest clients, representing approximately 70% of its 2024 revenues. By extending these long-term agreements, Claritev aims to reinforce its commitment to stability and growth, enhancing its industry positioning and ensuring continued partnerships with core clients.

The most recent analyst rating on (CTEV) stock is a Hold with a $54.00 price target. To see the full list of analyst forecasts on Claritev stock, see the CTEV Stock Forecast page.

Claritev Appoints New Chief Accounting Officer

On September 23, 2025, Claritev Corporation announced the appointment of Brock Albinson as Senior Vice President and Chief Accounting Officer, effective September 29, 2025. Mr. Albinson, who previously held significant financial roles at Automatic Data Processing, Inc., will replace Gerald Kozel and bring extensive experience from his tenure at both ADP and PricewaterhouseCoopers. This strategic appointment is expected to enhance Claritev’s financial management capabilities, aligning with the company’s growth objectives. Mr. Albinson’s compensation package includes a base salary of $375,000, an annual cash incentive award, and eligibility for long-term incentive grants, reflecting the company’s commitment to attracting top-tier talent.

The most recent analyst rating on (CTEV) stock is a Buy with a $86.00 price target. To see the full list of analyst forecasts on Claritev stock, see the CTEV Stock Forecast page.

Claritev Releases New Investor Presentation on Website

On September 3, 2025, Claritev Corporation announced the availability of a new slide presentation for investors on its website. This presentation, which is part of a regulatory compliance effort, outlines forward-looking statements about the company’s strategic and financial plans, including transformation and expansion initiatives. The presentation also discusses non-GAAP financial measures such as EBITDA and Free Cash Flow, which are used to evaluate the company’s performance and operational efficiency. The announcement highlights the company’s focus on strategic growth and financial performance, although it also acknowledges potential risks and uncertainties that could impact future results.

The most recent analyst rating on (CTEV) stock is a Buy with a $86.00 price target. To see the full list of analyst forecasts on Claritev stock, see the CTEV Stock Forecast page.

Claritev Corporation Reports Q2 2025 Financial Results

Claritev Corporation, formerly known as MultiPlan, is a healthcare technology, data, and insights company that focuses on enhancing affordability, transparency, and quality within the U.S. healthcare system by leveraging advanced technology and data analytics.

Claritev Corporation’s Supplier Dependency: A Risk to Financial Stability and Market Position

Claritev Corporation faces a significant business risk due to its heavy reliance on a single supplier for key raw materials. This dependency exposes the company to potential supply chain disruptions, which could arise from geopolitical tensions, natural disasters, or supplier financial instability. Such disruptions may lead to increased costs, production delays, and an inability to meet customer demand, ultimately affecting Claritev’s market position and financial performance. Diversifying its supplier base could mitigate these risks and enhance operational resilience.